Recent Articles from GlobeNewswire

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) --

Wellington, FL, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Author and communications specialist Stan Taylor announces growing sales of his book, The Black Book of Power, a study of psychological manipulation, power dynamics, and persuasion psychology. The book examines how influence techniques are used in politics, business, and media—and how individuals can learn to see and understand them.

Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of life

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) --

Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction in proteinuria, with a favorable safety profile

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and cardiometabolic diseases, including pericarditis and atherosclerosis

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Data Breach Victims to Contact the Firm

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today presented two posters for JADE101, its investigational anti-A PRoliferation-Inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobulin A nephropathy (IgAN), at the American Society of Nephrology (ASN) Kidney Week 2025.

Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) --

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In V.F. Corporation (VFC) To Contact Him Directly To Discuss Their Options

- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated:

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lantheus (LNTH) To Contact Him Directly To Discuss Their Options

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) --

The Open Coalition on Compliance Carbon Markets, announced by leaders from 10 countries and the European Union, draws from a proposal from the Global Climate Policy Project at Harvard and MIT.

A national innovation supporting future-ready cities and major global event readiness…through a strategic partnership for transforming national crisis response

XIAMEN, China, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, was recognized with the “Social Responsibility Golden Bull Award” at the 2025 Xiamen Industry Development Conference and Listed Companies (Hong Kong) Golden Bull Awards Ceremony, organized by China Securities Journal.

Participants included Florida Lieutenant Governor Jay Collins, The Babylon Bee’s Seth Dillon, and social media influencer Officer Tatum, among other leading voices

Florida’s ergonomic design leader introduces a modular workspace collection that unites craftsmanship, adaptability, and sustainability to create the future of human-centered work environments

Camarillo, CA, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Smile Spa Camarillo, a modern dental office led by Dr. Joelle Abed Elahad and Dr. Shawn Nguyen, is proud to announce that it has officially opened its doors at 400 W Ventura Blvd, Suite 240, in Camarillo, California. Conveniently located in the heart of Ventura County with easy access from Highway 101, the practice is now fully operational and welcoming patients from Camarillo and neighboring communities looking for patient-centered and tech-driven dental care.

MEXICO CITY, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE & BMV: AERO) (“Aeroméxico”) will hold a live conference call and webcast on Wednesday, November 12, 2025, at 10:00 a.m. Mexico City Time (11:00 a.m. Eastern Time) to discuss its third quarter 2025 financial results.

BRISBANE, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) through the Accelerated Approval Program for atacicept for the treatment of adults with immunoglobulin A nephropathy (IgAN).

PARSIPPANY, N.J., and TEL AVIV, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of new data from the ongoing, real-world IMPACT-TD Registry. The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led to reductions in the severity of involuntary movements and improvements in patient-reported quality of life. The data were presented at the 2025 Neuroscience Education Institute Fall Congress, taking place November 6 – 9, 2025 in Colorado Springs, Colorado.

EL SEGUNDO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- As previously announced, Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, will host its conference call to discuss its financial results for the third quarter ended September 27, 2025 on Tuesday, November 11, 2025 at 5:00 p.m. Eastern, 2:00 p.m. Pacific. However, the Company announced today that it will now report its financial results for the third quarter ended September 27, 2025 on Monday, November 10, 2025, one day earlier than previously indicated.

NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) securities during the period of August 6, 2024 through August 4, 2025, inclusive (“the Class Period”).

Vancouver, BC, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has granted an aggregate 831,356 restricted share units (“RSUs”) and 20,964 stock options (“Options”) to consultants and employees of the Company and its subsidiary, Rocket Doctor Inc.

Among the Nation’s Most Trusted Nonprofits

Legacy Housing’s book value per share rose by 10.2% year-over-year, reflecting ongoing financial resilience.

Oral presentation of biomarker data shows RP1 plus nivolumab reverses multiple resistance mechanisms to PD-1 blockade in advanced melanoma following definitive anti-PD-1 failure

Lasme-cel in r/r B-ALL (BALLI-01)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on November 3, 2025 (the “Grant Date”), ORIC granted a total of 18,400 non-qualified stock options and 3,000 restricted stock units to one new non-executive employee who began their employment with ORIC in October 2025.

CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

Orlando, Nov. 07, 2025 (GLOBE NEWSWIRE) -- — CNL Strategic Capital, LLC (CNL Strategic Capital or the Company) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the nine months ended Sept. 30, 2025.

PITTSBURGH, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its fourth quarter and fiscal year 2025 earnings results after the market closes on Thursday, November 20, 2025.

PETACH TIKVA, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2025, before market open on Thursday, November 20, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

-- Zola® year-to-date revenues increase 26% year over year ---- Arcadia gross profit margins exceed 30% for 11th straight quarter ---- Arcadia cash balance declines by only $257K to $1.1M --

BRISBANE, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on November 4, 2025, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 79,050 shares of Class A common stock and restricted stock units (RSUs) underlying 39,915 shares of Class A common stock to six (6) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

SHENZHEN, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Mingzhu Logistics Holdings Limited (“Mingzhu” or the “Company”) (Nasdaq: YGMZ), an elite provider of logistics and transportation services to businesses, today announced that it will effect a reverse share split of its outstanding ordinary shares, par value $0.008 per share (the “Ordinary Shares”), at a ratio of 1-for-16, to be effective at the open of business on Wednesday, November 12, 2025.

WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the company presented data, including results from the first real-world study of XPHOZAH, at American Society of Nephrology’s Kidney Week, currently underway in Houston.

The artisan-crafted furnishings brand debuts its first Montana location at Bozeman’s Gallatin Crossing

MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the closing of its upsized initial public offering of 5,233,765 shares of its Class A common stock, which includes the exercise in full of the underwriters’ option to purchase an additional 682,665 shares of Class A common stock at a public offering price of $60.00 per share, less underwriting discounts and commissions. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by BillionToOne, were approximately $314.0 million. BillionToOne’s Class A common stock began trading on the Nasdaq Global Select Market on November 6, 2025, under the ticker symbol “BLLN.”

NAARDEN, The Netherlands and MIAMI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 18,000 of NewAmsterdam’s ordinary shares to one non-executive new hire. The share options were granted as an inducement material to the employee’s acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).

OMAHA, NE, Nov. 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the third quarter of fiscal 2025 on Thursday, November 13, 2025.

Podcast Broadcast Central (PBC) combines decades of broadcast news, reality TV and digital expertise to offer a one-stop studio for modern content creators.

SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Fiserv, Inc. (NYSE: FI) securities between July 23, 2025 and October 29, 2025. Fiserv is a Milwaukee, Wisconsin-based global payments and financial technology provider.

SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Six Flags Entertainment Corporation (NYSE: FUN) common stock pursuant or traceable to the Company’s registration statement and prospectus issued in connection with the July 1, 2024 merger of Legacy Six Flags with Cedar Fair, L.P., and their subsidiaries and affiliates. Cedar Fair and Legacy Six Flags combined two amusement parks to create North America’s largest regional amusement park operator with a property portfolio of approximately 40 amusement parks and water parks, along with several resort properties.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Trex To Contact Him Directly To Discuss Their Options

HIGH POINT, N.C., Nov. 07, 2025 (GLOBE NEWSWIRE) -- High Point University welcomed approximately 2,500 veterans, family members and community guests to the Nido and Mariana Qubein Arena and Conference Center today for its 15th Annual Veterans Day Celebration, honoring those men and women who have served and sacrificed for our country.

LAS VEGAS, Nevada, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it will hold a conference call on Tuesday, November 11, 2025 at 1:00 p.m. ET to discuss its third quarter 2025 operating results.

LENEXA, Ks., Nov. 07, 2025 (GLOBE NEWSWIRE) -- On November 1, 2025, CommunityAmerica Credit Union officially merged with UNIFY Financial Credit Union, expanding its national footprint with branch locations across Arkansas, California, Nevada, Tennessee, and Texas.

Encinitas, CA, Nov. 07, 2025 (GLOBE NEWSWIRE) -- All Smiles Dental Studio, a leading dental care provider serving North County San Diego, is pleased to announce the expansion of its services by offering comprehensive dental implant solutions, alongside the introduction of a new in-house membership plan designed to improve access to care for the local Encinitas community.

High-Energy Night Features Hip-Hop Icons Nelly, Fat Joe and Rev Run

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Six Flags (FUN) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire Medical (INSP) To Contact Him Directly To Discuss Their Options

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Following a challenge submitted by Pfizer, Inc., BBB National Programs’ National Advertising Division will refer BridgeBio Pharma Inc. to the relevant government agencies for review and possible enforcement action for failure to participate in the National Advertising Division (NAD) inquiry.

Palmetto Publishing Announces: A mother’s fight for justice unfolds as her son faces life-altering paralysis after a mysterious fraternity “incident.” With the help of a determined attorney, she confronts a web of secrecy, hazing and cover-ups by powerful institutions in a gripping legal battle that exposes dark truths.

MINNETONKA, Minn., Nov. 07, 2025 (GLOBE NEWSWIRE) -- On November 7, 2025, The Board of Directors of Table Trac Inc. (the “Company”) (OTCQX: TBTC) approved a cash dividend on the Company’s common stock of $0.02 per share. The dividend is payable on December 12, 2025, to shareholders of record at the close of business on November 28, 2025.

 

Transaction in Own Shares   

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Alvotech (ALVO) To Contact Him Directly To Discuss Their Options

COLUMBUS, Wis., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Michael S. Eisenga, Chief Executive Officer of First American Properties, today issued a statement in response to the latest University of Michigan Consumer Sentiment Index and layoff data from Challenger, Grey & Christmas, which together point to a clear slowdown in economic activity and rising financial pressure across American households.

Raleigh, NC, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Hybrid Geek, a leader in hybrid battery technology and mobile installation, is expanding its national footprint with a sweeping, multi-phase rollout set to reach more than 44 U.S. states by mid-2026. Known for its mobile diagnostic-first service model and sustainable sodium-ion battery innovations, the company is redefining how drivers access high-performance hybrid care in the EV era.

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Now in its 10th season, Edmunds U-Drags builds on Edmunds’ independent track and real-world testing to help everyday car shoppers find their next vehicle

OSE Immunotherapeutics Presents a Poster on OSE-Cytomask®, a Novel “Cis-Demasking” Cytokine Technology to Increase Therapeutic Index of Immunocytokines

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Wildermuth Fund (“Wildermuth” or “the Company”) (WESFX, WEFCX, WEIFX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

IO DeFi Launches New Mobile App, Making Digital Asset Earnings Accessible to Everyone

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.